Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market
Holding PVCT?
Track your performance easily

Provectus Pharmaceuticals (PVCT) Financial Statements

77 Followers

Provectus Pharmaceuticals Financial Overview

Provectus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.006; its P/E ratio is -13.64; Provectus Pharmaceuticals is scheduled to report earnings on May 9, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 254.99K$ 238.07K$ 69.70K$ 161.84K$ 205.03K
Gross Profit$ 254.99K$ 238.07K$ 69.73K$ 161.84K$ 205.03K
EBIT$ -785.55K$ -447.26K$ -714.32K$ -784.24K$ 1.19M
EBITDA$ -783.32K$ -445.03K$ -712.09K$ -782.01K$ 1.19M
Net Income Common Stockholders$ -846.85K$ -504.04K$ -775.80K$ -835.06K$ 1.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.58K$ 18.04K$ 367.25K$ 1.36M$ 1.32M
Total Assets$ 856.43K$ 1.08M$ 1.69M$ 1.69M$ 1.72M
Total Debt$ 159.84K$ 252.66K$ 937.93K$ 319.48K$ 837.16K
Net Debt$ 130.26K$ 234.62K$ 570.68K$ -1.04M$ -484.29K
Total Liabilities$ 8.37M$ 5.43M$ 9.21M$ 8.98M$ 8.72M
Stockholders Equity$ -7.51M$ -7.46M$ -7.52M$ -7.30M$ -7.00M
Cash Flow-
Free Cash Flow$ -762.59K$ -1.04M$ -768.87K$ -628.51K$ -613.38K
Operating Cash Flow$ -762.59K$ -1.04M$ -768.87K$ -628.51K$ -613.38K
Investing Cash Flow-----
Financing Cash Flow$ 588.95K$ 781.10K$ 817.86K$ 656.44K$ 515.70K
Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History

Provectus Pharmaceuticals Debt to Assets

Provectus Pharmaceuticals Cash Flow

Provectus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis